Elaitra raises €81K Pre-Seed round

27 January 2022· London, United Kingdom· health, radiology, ai, b2b, pure_software

As part of the Cancer Tech Accelerator Phase II, the grant funding was provided to progress the development and clinical proof of concept for Elaitra's 3D AI breast cancer detection technology.

Investors

LeadCancer Research UK

Also participating

Roche UKMedical Research Council

About Elaitra

Stage

Pre-Seed

Headquarters

London, United Kingdom

Founded

2015

Team Size

6–20

Sectors

healthradiologyaib2bpure_software

https://elaitra.com/

Source: https://www.cancertechaccelerator.co.uk/meet-our-cancer-tech-finalists/